Creative Biogene, a global leader in the field of biotechnology and genomics research, has now added an advanced PEM-Seq service to their cutting-edge CRISPR/Cas9 Platform. This paradigm-shifting scientific breakthrough provides an efficient, cost-effective tool for genomics researchers and investigators globally, further cementing Creative Biogene’s industry-leading position.

CRISPR/Cas9, often synonymous with the future of genetic engineering, is a revolutionary tool used extensively to manipulate genomes and fundamentally change genetic research. The inclusion of the PEM-Seq service – short for Parkin E3 ubiquitin-protein ligase Mitochondrial Sequencing – fosters superior scientific innovation by providing precise and specific detection of mitochondrial DNA sequences.

PEM-Seq leverages the power of next-generation sequencing platforms to deliver high-resolution profiling data, allowing researchers to explore and understand the complex world of genetic variations with an unprecedented degree of detail. This advanced technology significantly contributes to accelerating pathways in genetic disease research and novel therapeutic discovery.

Creative Biogene’s CRISPR/Cas9 platform is esteemed for its efficient and precise genome-editing capabilities, and coupling it with the PEM-Seq service amplifies its potential for genomic research and disease modeling exponentially.

The PEM-Seq service now offered at Creative Biogene's CRISPR/Cas9 Platform continues to push the boundaries of genetic engineering by granting scientists everywhere access to leading-edge technology, promoting the acceleration of advancements in areas such as disease diagnosis, personalized medicine, and advanced therapeutics.

For the scientific community, this evolution reaffirms Creative Biogene's commitment to investing in superior solutions for resisting disease, providing more optimistic forecasts for various medical sciences, and ultimately, serving humanity more efficiently.

Creative Biogene's team of highly skilled professionals provides clients with full support, addressing specific needs and goals related to genetic research and practical applications in the field of biotechnology.

Experience the next level of genetic innovation with Creative Biogene's CRISPR/Cas9 platform and newfound PEM-Seq service, as we continue to reinvent the biological landscape, taking genetic discoveries to new peaks of excellence.

About Creative Biogene

Creative Biogene, headquartered in the USA, is a world leader in biotechnology and genomics research. The company focuses on developing unique technologies that provide innovative, tailored solutions for their clients, helping scientists and researchers overcome challenges in the genetic field.